SurveySoNeTNCT05617079
The State of Nebulizer Therapy in Russian Federation
An observational study of Survey and Respiratory Failure, run by Russian Federation of Anesthesiologists and Reanimatologists at 1 site in Russia.
Trial summary
It is known that the inhalation (nebulizer) use of drugs is of great importance in the intensive care of patients with acute and chronic respiratory failure of various origins. Searching PubMed data for the last 5 years (2017-2022) for the keywords "nebulizer therapy" revealed 533 publications, and "mesh nebulizer… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Survey, Respiratory Failure, Respiratory Disease
- What is being tested?
- Survey
- How many people
- 370 participants
- Where
- 1 siteRussia
- Study dates
- 1 Jul 2023to 31 Jul 2025
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Medicine physicians (VMP) practicing in the hospital and in the community settings.
Who may be able to join
- Medical physicians
Who cannot join
- Lack of experience in conducting nebulizer therapy. Lack of technical capability for nebulizer therapy in a medical organization.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The State of Nebulizer Therapy in Russian Federation: a National Survey Among Medicine Physicians
It is known that the inhalation (nebulizer) use of drugs is of great importance in the intensive care of patients with acute and chronic respiratory failure of various origins.
Searching PubMed data for the last 5 years (2017-2022) for the keywords "nebulizer therapy" revealed 533 publications, and "mesh nebulizer therapy" - only 25 sources.
Read more
During the same period, the national database (E-Library) has 75 publications for the keywords "nebulizer therapy", and 4 sources for "mesh nebulizer therapy".
It should be noted that almost all publications are devoted to the use of nebulizers for specific diseases and pathological syndromes. There are no works evaluating the adherence of specialists, systemic indications and actually used methods.
The aim of trial is to study the current state of the use of nebulizer therapy in medical organizations and identify ways to improve its effectiveness This study is planned to be carried out using a questionnaire using a database based on the Internet electronic survey form.
Read the detailed description
We intend to involve at least 3 medical organizations in the subjects of the Russian Federation with a population of up to 1 million people; at least 5 medical organizations in the constituent entities of the Russian Federation with a population level of 1 to 3 million people, at least 7 organizations with a population level of more than 3 million people. In cities of the Russian Federation with a population of 1 million people or more - at least 5 medical organizations, and in the cities of Moscow and St. Petersburg - at least 10 medical organizations.
- Conditions
- Survey, Respiratory Failure, Respiratory Disease
- Being tested
- Survey
- Medical subject headings
- Respiratory Insufficiency, Respiration Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SurveyOther
an electronic survey will be conducted
| Study group | Role | What they receive |
|---|---|---|
| Medicine physicians | Anesthesiologists, intensive care specialists, heads of departments of anesthesiology and intensive care, deputy chief physicians for anesthesiology and intensive care (heads of centers), employees of the department of anesthesiology and intensive care, pulmonologists working in medical organizations that use nebulizer therapy. Receives: Other: Survey |
What is being measured
The primary outcome is the main question the study is designed to answer.
Structure of indications, methods and frequency of use of nebulizer therapy
Registration of the structure and indications for nebulizer therapy
Measured: up to 1 month after inclusion
Secondary outcomes (2)
Drugs and frequency of their use during nebulizer therapy
Registration of drugs used for nebulizer therapy
Measured: up to 6 month after inclusion
The frequency of use of nebulizer therapy for high-flow oxygen therapy, non-invasive ventilation and mechanical ventilation
Frequency of use of nebulizer therapy for various types of respiratory support
Measured: up to 6 month after inclusion
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Nov 2022
- Study start1 Jul 2023
- Primary completion30 Jun 2024
- Study completion31 Jul 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for SurveyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 370 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Russian Federation of Anesthesiologists and Reanimatologists
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Alexey Gritsan, MD, Principal investigator, Krasnoyarsk State Medical University n.a. prof. V.F. Voyno-Yasenetsky
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05617079
- Sponsor's protocol ID
- FARCT0004
- Acronym
- SoNeT
- Status last verified
- Apr 2025
- First submitted
- 7 Nov 2022
- Last updated
- 4 Apr 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 4 Apr 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The State of Nebulizer Therapy in Russian Federation: a National Survey Among Medicine Physicians
- ClinicalTrials.gov ID
- NCT05617079
- Acronym / sponsor ID
- SoNeT / FARCT0004
- Conditions
- Survey, Respiratory Failure, Respiratory Disease
- Study type
- Observational
- Recruitment status
- Active, not recruiting
- Enrolment
- 370 participants (estimated)
- Lead sponsor
- Russian Federation of Anesthesiologists and ReanimatologistsUniversity, hospital or other
- Study start
- 1 Jul 2023 (actual)
- Primary completion
- 30 Jun 2024 (actual)
- Study completion
- 31 Jul 2025 (estimated)
- First posted
- 15 Nov 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
It is known that the inhalation (nebulizer) use of drugs is of great importance in the intensive care of patients with acute and chronic respiratory failure of various origins.
Searching PubMed data for the last 5 years (2017-2022) for the keywords "nebulizer therapy" revealed 533 publications, and "mesh nebulizer therapy" - only 25 sources.
During the same period, the national database (E-Library) has 75 publications for the keywords "nebulizer therapy", and 4 sources for "mesh nebulizer therapy".
It should be noted that almost all publications are devoted to the use of nebulizers for specific diseases and pathological syndromes. There are no works evaluating the adherence of specialists, systemic indications and actually used methods.
The aim of trial is to study the current state of the use of nebulizer therapy in medical organizations and identify ways to improve its effectiveness This study is planned to be carried out using a questionnaire using a database based on the Internet electronic survey form.
Detailed description
We intend to involve at least 3 medical organizations in the subjects of the Russian Federation with a population of up to 1 million people; at least 5 medical organizations in the constituent entities of the Russian Federation with a population level of 1 to 3 million people, at least 7 organizations with a population level of more than 3 million people. In cities of the Russian Federation with a population of 1 million people or more - at least 5 medical organizations, and in the cities of Moscow and St. Petersburg - at least 10 medical organizations.
Study design
- Observational model
- Other
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Medicine physicians | – | Other: SurveyAnesthesiologists, intensive care specialists, heads of departments of anesthesiology and intensive care, deputy chief physicians for anesthesiology and intensive care (heads of centers), employees of the department of anesthesiology and intensive care, pulmonologists working in medical organizations that use nebulizer therapy. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Medicine physicians (VMP) practicing in the hospital and in the community settings.
Key inclusion criteria (1 listed)
- Medical physicians
Key exclusion criteria (1 listed)
- Lack of experience in conducting nebulizer therapy. Lack of technical capability for nebulizer therapy in a medical organization.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Surveyan electronic survey will be conducted | Other | Medicine physicians |
Primary outcome
Structure of indications, methods and frequency of use of nebulizer therapy
Time frame: up to 1 month after inclusion
Registration of the structure and indications for nebulizer therapy
2 secondary outcomes
Drugs and frequency of their use during nebulizer therapy
Time frame: up to 6 month after inclusion
The frequency of use of nebulizer therapy for high-flow oxygen therapy, non-invasive ventilation and mechanical ventilation
Time frame: up to 6 month after inclusion
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Apr 2025.
- Individual participant dataSharing planned: No
Related trials for Survey
Recruiting
Empowered Relief® for Cancer Survivors With Chronic Pain
Chronic Pain Due to Cancer, Pain Catastrophizing
RecruitingObservational study
Survey to Determine Incarcerated Persons' Views on Surrogate Decision Making
Healthy Volunteers
Not yet recruitingObservational study
Clinical Genetics Branch Eligibility Screening Survey
Melanoma, Li-Fraumeni Syndrome
Not yet recruitingObservational study
End of Term vs. End of Module Examinations in the Preclinical Stage: A Cross-Sectional Survey of Student and Faculty Perspectives
Student and Faculty Perspectives About Examinations
Not yet recruitingObservational study
Common Carotid Artery-Renal Artery-Femoral Artery Survey for Hypertension
Hypertension, Hypertension (HTN)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Alexey Gritsan, MD principal investigator
Krasnoyarsk State Medical University n.a. prof. V.F. Voyno-Yasenetsky
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Survey and Respiratory Failure, run by Russian Federation of Anesthesiologists and Reanimatologists at 1 site in Russia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 4 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Russia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Structure of indications, methods and frequency of use of nebulizer therapy (time frame: up to 1 month after inclusion). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Apr 2025.